Loading…
Embecta Corp. is projected to decline to $3.18 by 2027, a -3% move from its current price of $3.29. EMBC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.17 | $3.29 | $3.42 | -0.02% |
| May 30 | $3.12 | $3.29 | $3.47 | -0.04% |
| May 31 | $3.08 | $3.29 | $3.51 | -0.06% |
| Jun 1 | $3.05 | $3.29 | $3.55 | -0.07% |
| Jun 2 | $3.02 | $3.29 | $3.58 | -0.09% |
| Jun 3 | $3.00 | $3.29 | $3.61 | -0.11% |
| Jun 4 | $2.97 | $3.29 | $3.63 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.97 | $3.29 | $3.63 | -0.13% |
| Week 2 | $2.85 | $3.28 | $3.78 | -0.26% |
| Week 3 | $2.76 | $3.28 | $3.90 | -0.39% |
| Week 4 | $2.68 | $3.27 | $4.00 | -0.52% |
| Week 5 | $2.61 | $3.27 | $4.09 | -0.65% |
| Week 6 | $2.56 | $3.26 | $4.17 | -0.78% |
| Week 7 | $2.50 | $3.26 | $4.25 | -0.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Embecta Corp. is a medical device company focused on diabetes care for people in the United States and internationally.
Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
It was formerly known as Berra Newco, Inc. Embecta was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp. trades under the symbol EMBC and has a current price of $3.32.
Its market capitalization is $196.97M and it is ranked 3857.
The near-term forecast shows mixed signals, with 2026 avg $3.32 (sentiment NEUTRAL) and later years featuring higher averages, including 2029 avg $4.28 and 2030 avg $4.53, and culminating in 2050 avg $11.02 with a max of $23.98.
Overall, these forecasts point to bullish momentum in later years, but are estimates, not guarantees.
A major floor 11.9% below — a decisive break under it would weaken the trend.
The nearest floor, 11.9% below — buyers have tended to step in here.
The nearest ceiling, 197.3% above — a clean break opens room to run.
A major ceiling 276.6% above — clearing it would confirm fresh momentum.
Key EMBC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EMBC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.26 | Buy | $3.27 | Buy |
| MA 10 | $3.16 | Buy | $3.48 | Sell |
| MA 20 | $4.47 | Sell | $4.46 | Sell |
| MA 50 | $7.23 | Sell | $6.55 | Sell |
| MA 100 | $8.99 | Sell | $8.34 | Sell |
| MA 200 | $11.30 | Sell | $10.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.78 | Buy |
| Stoch RSI (14) | 97.69 | Sell |
| CCI (20) | -42.73 | Neutral |
| Williams %R (14) | -47.30 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | -9.62 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 52.70 | Neutral |
| TRIX (15) | -3.03 | Sell |
| Awesome (5,34) | -3.19 | Sell |
| Ultimate (7,14,28) | 48.71 | Neutral |
| Momentum (10) | -0.12 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 3.38 | Sell |
| ADX (14) | 49.73 | Sell |
| ATR (14) | 0.24 | Info |
Near-term sentiment is NEUTRAL. RSI14 is 20.
SMA50 is $7.45 and SMA200 is $11.38, signaling resistance above the current price.
Support is at $2.90 and resistance at $9.78. The 30-day range runs from $2.55 to $4.33. Annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.90 | $3.29 | $3.96 | 0% | Neutral | |
| $2.43 | $3.18 | $4.46 | -3% | Neutral | |
| $2.39 | $3.26 | $4.79 | -1% | Neutral | |
| $2.98 | $4.19 | $6.40 | +27% | Bullish | |
| $3.09 | $4.49 | $7.06 | +36% | Bullish | |
| $2.66 | $3.96 | $6.40 | +20% | Bullish | |
| $2.83 | $4.33 | $7.16 | +31% | Bullish | |
| $2.71 | $4.25 | $7.18 | +29% | Bullish | |
| $2.57 | $4.13 | $7.13 | +26% | Bullish | |
| $3.39 | $5.57 | $9.78 | +69% | Bullish | |
| $3.34 | $6.09 | $11.54 | +85% | Bullish | |
| $4.95 | $10.95 | $23.16 | +233% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.90 | $3.29 | $3.90 | +0.00% |
| June 2026 | $2.83 | $3.35 | $4.08 | +1.77% |
| July 2026 | $2.70 | $3.23 | $4.01 | -3.39% |
| August 2026 | $2.69 | $3.25 | $4.09 | +0.58% |
| September 2026 | $2.74 | $3.34 | $4.25 | +2.52% |
| October 2026 | $2.61 | $3.20 | $4.11 | -4.13% |
| November 2026 | $2.44 | $3.01 | $3.91 | -5.73% |
| December 2026 | $2.44 | $3.03 | $3.96 | +0.44% |
Click any year to see its month-by-month EMBC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, EMBC could reach as high as $3.96, with a base case around $3.29 and support toward $2.90 — roughly 0% from $3.29. Price action looks broadly range-bound.
Expect EMBC to range from $2.43 to $4.46 through 2027. The $3.18 average target implies a -3% move from current prices. That is -3% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The EMBC price prediction for 2028 points to an average of $3.26 (low $2.39, high $4.79) — a potential decline of -1% on today's $3.29. Price action looks broadly range-bound.
In 2029, EMBC is projected to trade between $2.98 and $6.40, averaging $4.19 — a potential gain of +27% from today's $3.29. That is up +29% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Embecta Corp.'s 2030 outlook centres on $4.49, within a $3.09 to $7.06 range. That is up +7% on the projected 2029 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2031, EMBC could reach as high as $6.40, with a base case around $3.96 and support toward $2.66 — roughly +20% from $3.29. Buyers look set to stay in control over this stretch.
Expect EMBC to range from $2.83 to $7.16 through 2032. The $4.33 average target implies a +31% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The EMBC price prediction for 2033 points to an average of $4.25 (low $2.71, high $7.18) — a potential gain of +29% on today's $3.29. Buyers look set to stay in control over this stretch.
In 2034, EMBC is projected to trade between $2.57 and $7.13, averaging $4.13 — a potential gain of +26% from today's $3.29. That is -3% versus the projected 2033 average. Momentum favours further upside here.
Embecta Corp.'s 2035 outlook centres on $5.57, within a $3.39 to $9.78 range. That is up +35% on the projected 2034 average. That marks a +69% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, EMBC could reach as high as $11.54, with a base case around $6.09 and support toward $3.34 — roughly +85% from $3.29. Momentum favours further upside here.
Expect EMBC to range from $4.95 to $23.16 through 2050. The $10.95 average target implies a +233% move from current prices. That is up +80% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in EMBC today (≈ 303.951368 EMBC) could be worth
$3,327.87
+$2,327.87 (+233%) by 2050 · US Dollar
Based on the average projected EMBC price of $10.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EMBCwould be worth at today's price.
$1,000 invested in EMBC on May 27, 2025 (≈ 88.809945 EMBC) would be worth
$292.18
-$707.82 (-70.8%) today · 0.29× · US Dollar
Based on a EMBC entry price of $11.26 vs. today's $3.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.06 | $1,075.16 | +7.5% |
| 1 month ago | $9.24 | $356.06 | -64.4% |
| 3 months ago | $10.48 | $313.93 | -68.6% |
| 6 months ago | $12.76 | $257.94 | -74.2% |
| 1 year ago | $11.26 | $292.18 | -70.8% |
| All time (4.2y) ago | $47 | $70 | -93.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EMBC forecast.
Our base-case forecast reaches $6.60 around 2050.
Implied market cap at $6.60: $391.56M
The multi-year forecast shows several years with bullish sentiment as averages rise from the late 2020s onward.
In 2029 the avg is $4.28 with ROI 28.8 and sentiment BULLISH; in 2030 the avg is $4.53 with ROI 36.5 and sentiment BULLISH.
The forecast extends to 2032 (avg $4.39, ROI 32.2) and 2035 (avg $5.70, ROI 71.7), with continued upside into 2040 (avg $6.12, ROI 84.5).
By 2050 the avg is $11.02 with ROI 232 and a max of $23.98, all carrying a BULLISH sentiment. These are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030 the avg forecast is $4.53 with a max of $7.25 and ROI 36.5, with sentiment BULLISH.
Forecasts show neutral signals in 2026, then bullish in 2029–2050 with an avg path to $11.02 by 2050 and a max of $23.98. ROI figures reach up to 232, but these are estimates, not guarantees.
Yes. The forecast shows a max of $10.23 in 2035 and a max of $23.98 in 2050, indicating the possibility of crossing $10 in later years.
Current price $3.32 and market cap $196.97M.
The 30-day range is $2.55 to $4.33.
Embecta Corp. Community Discussion
0Share your Embecta Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.